Molecular biology of breast cancer metastasis - Molecular expression of vascular markers by aggressive breast cancer cells

被引:83
作者
Hendrix, MJC
Seftor, EA
Kirschmann, DA
Seftor, REB
机构
[1] Univ Iowa, Coll Med, Dept Anat & Cell Biol, Iowa City, IA 52242 USA
[2] Univ Iowa, Ctr Canc, Iowa City, IA 52242 USA
来源
BREAST CANCER RESEARCH | 2000年 / 2卷 / 06期
关键词
breast cancer; interconverted phenotype; thrombin receptor; TIE2;
D O I
10.1186/bcr88
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
During embryogenesis, the formation of primary vascular networks occurs via the processes of vasculogenesis and angiogenesis. In uveal melanoma, vasculogenic mimicry describes the 'embryonic-like' ability of aggressive, but not nonaggressive, tumor cells to form networks surrounding spheroids of tumor cells in three-dimensional culture; these recapitulate the patterned networks seen in patients' aggressive tumors and correlates with poor prognosis. The molecular profile of these aggressive tumor cells suggests that they have a deregulated genotype, capable of expressing vascular phenotypes. Similarly, the embryonic-like phenotype expressed by the aggressive human breast cancer cells is associated with their ability to express a variety of vascular markers. These studies may offer new insights for consideration in breast cancer diagnosis and therapeutic intervention strategies.
引用
收藏
页码:417 / 422
页数:6
相关论文
共 53 条
  • [41] Regulation of endothelin-B receptor mRNA expression in human endothelial cells by cytokines and growth factors
    Smith, PJW
    Teichert-Kuliszewska, K
    Monge, JC
    Stewart, DJ
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1998, 31 : S158 - S160
  • [42] Takahama M, 1999, CLIN CANCER RES, V5, P2506
  • [43] Thomas PA, 1999, CLIN CANCER RES, V5, P2698
  • [44] TIMAR J, 1922, PATH9OL ONCOL RES, V6, P3
  • [45] On the mechanism of thrombin-induced angiogenesis - Potentiation of vascular endothelial growth factor activity on endothelial cells by up-regulation of its receptors
    Tsopanoglou, NE
    Maragoudakis, ME
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (34) : 23969 - 23976
  • [46] VAUPEL P, 1989, CANCER RES, V49, P6449
  • [47] WARREN BA, 1966, LAB INVEST, V15, P464
  • [48] Warren BA, 1979, TUMOR BLOOD CIRCULAT, P1
  • [49] Weidner N, 1998, J PATHOL, V184, P119, DOI 10.1002/(SICI)1096-9896(199802)184:2<119::AID-PATH17>3.0.CO
  • [50] 2-D